DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,798 | +29.4% | 3,264 | +25.2% | 0.28% | +32.5% |
| Q2 2023 | $625,920 | +18.6% | 2,608 | +24.5% | 0.21% | +8.2% |
| Q1 2023 | $527,772 | +3.2% | 2,094 | +8.7% | 0.20% | -5.8% |
| Q4 2022 | $511,464 | +7.7% | 1,927 | +4.7% | 0.21% | -0.5% |
| Q3 2022 | $475,000 | +33.1% | 1,840 | +30.8% | 0.21% | +38.4% |
| Q2 2022 | $357,000 | -99.9% | 1,407 | +9.8% | 0.15% | +13.5% |
| Q1 2022 | $376,049,000 | +61.7% | 1,282 | +81.3% | 0.13% | +66.2% |
| Q4 2021 | $232,610,000 | +108090.7% | 707 | 0.0% | 0.08% | -3.6% |
| Q3 2021 | $215,000 | -81.6% | 707 | -94.1% | 0.08% | -77.8% |
| Q1 2018 | $1,168,000 | +7.3% | 11,934 | +1.7% | 0.37% | +8.4% |
| Q4 2017 | $1,089,000 | +94.1% | 11,734 | +79.5% | 0.34% | +74.2% |
| Q3 2017 | $561,000 | +1.6% | 6,537 | 0.0% | 0.20% | -2.5% |
| Q2 2017 | $552,000 | -1.3% | 6,537 | 0.0% | 0.20% | -2.9% |
| Q1 2017 | $559,000 | +23.1% | 6,537 | +12.0% | 0.21% | +16.8% |
| Q4 2016 | $454,000 | +6.1% | 5,837 | +6.8% | 0.18% | +1.1% |
| Q3 2016 | $428,000 | -13.9% | 5,466 | +4.3% | 0.18% | -17.3% |
| Q1 2016 | $497,000 | +2.9% | 5,241 | +0.6% | 0.21% | +1.9% |
| Q4 2015 | $483,000 | -50.1% | 5,209 | -54.0% | 0.21% | -47.5% |
| Q2 2015 | $968,000 | +0.8% | 11,313 | 0.0% | 0.40% | +2.3% |
| Q1 2015 | $960,000 | +1.8% | 11,313 | +2.7% | 0.39% | -1.8% |
| Q4 2014 | $943,000 | +14.9% | 11,013 | +1.8% | 0.40% | +7.6% |
| Q3 2014 | $821,000 | +0.7% | 10,813 | +4.3% | 0.37% | -4.4% |
| Q2 2014 | $815,000 | +4.9% | 10,363 | 0.0% | 0.39% | -2.3% |
| Q1 2014 | $777,000 | +8.2% | 10,363 | +11.3% | 0.40% | +5.6% |
| Q4 2013 | $718,000 | – | 9,313 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |